Center for Scientific Review; Notice of Closed Meetings, 58547-58548 [2013-23082]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 185 / Tuesday, September 24, 2013 / Notices
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Suite 957, Bethesda, MD 20892,
301–496–4773, zhour@mail.nih.gov.
Dated: September 17, 2013.
Mary K. Wakefield,
Administrator.
[FR Doc. 2013–23074 Filed 9–23–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Medical Imaging
Study Section, October 07, 2013, 08:00
a.m. to October 08, 2013, 05:00 p.m.,
National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on September 10, 2013, FR 78
55268–55270.
The meeting will be held October 7,
2013, 9:30 a.m. to 5:30 p.m. The meeting
location remains the same. The meeting
is closed to the public.
Dated: September 18, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–23081 Filed 9–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; 2014–01 Reducing
Health Disparity SBIR Review.
Date: November 8, 2013.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
19:49 Sep 23, 2013
Jkt 229001
[FR Doc. 2013–23083 Filed 9–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurobiology, genetics, stress and mood/
anxiety disorders.
Date: October 10, 2013.
Time: 5:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Washington, DC
Convention Center, 900 10th Street NW.,
Washington, DC 20001.
Contact Person: Jay Joshi, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5196, MSC 7846, Bethesda, MD
20892, (301) 408–9135, joshij@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-HIV Microbial Vaccine
Development.
Date: October 18, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
58547
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biostatistical Methods and Research Design
Study Section.
Date: October 18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Inner Harbor, 301 W.
Lombard Street, Baltimore, MD 21201.
Contact Person: Tomas Drgon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3152,
MSC 7770, Bethesda, MD 20892, 301–435–
1017, tdrgon@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Biomarkers Study Section.
Date: October 18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Houston JW Marriott, 5150
Westheimer Road, Houston, TX 77056.
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–357–
9318, ngkl@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Host Interactions with Bacterial Pathogens
Study Section.
Date: October 18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Fouad A El-Zaatari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7808, Bethesda, MD 20892, (301) 435–
1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Risk, Prevention and Health
Behavior.
Date: October 18, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Claire E Gutkin, Ph.D.,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106,
MSC 7808, Bethesda, MD 20892, 301–594–
3139, gutkincl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Neuroscience of Channels and Receptors.
Date: October 18, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
E:\FR\FM\24SEN1.SGM
24SEN1
58548
Federal Register / Vol. 78, No. 185 / Tuesday, September 24, 2013 / Notices
Contact Person: Carol Hamelink, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 13–
213: Outcome Measures for Use in Treatment
Trials for Individuals with Intellectual and
Developmental Disabilities (R01).
Date: October 18, 2013.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jane A DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 13–008
Robotic Bioanalytical Shared
Instrumentation.
Date: October 18, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7804, Bethesda, MD 20892, belangerm@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–23082 Filed 9–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information: The National
Toxicology Program Requests
Information on Use, Human Exposure,
and Toxicity of Vinpocetine
To facilitate the design of
toxicological studies for vinpocetine
(CAS RN: 42971–09–5), the National
Toxicology Program (NTP) at the
National Institute of Environmental
Health Sciences (NIEHS) requests the
submission of available information
regarding (1) exposure,
pharmacokinetics, toxicity, safety, or
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:49 Sep 23, 2013
Jkt 229001
efficacy in humans; (2) production, use,
and consumption patterns in the United
States; (3) genotoxicity, repeated dose
toxicity, prenatal developmental
toxicity, reproductive toxicity, chronic
toxicity, and carcinogenicity studies in
experimental animals; and (4) any other
information relative to the safety or
toxicity of vinpocetine not listed above.
DATES: The deadline for receipt of
information is November 4, 2013.
ADDRESSES: Submission of information
via email to surhi@niehs.nih.gov is
preferred.
Dr.
Inok Surh, Research Fellow, Toxicology
Branch, Division of the NTP, NIH/
NIEHS, P.O. Box 12233, MD K2–12,
Research Triangle Park, NC 27709.
Phone: (919) 541–3862, Fax: (919) 541–
4255, Email: surhi@niehs.nih.gov. Hand
Delivery/Courier: 530 Davis Drive,
Room 2067, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: The National Cancer
Institute nominated the dietary
supplement vincamine to the NTP for
genotoxicity, subchronic toxicity, and
mechanistic studies due to a lack of
information on its potential toxicity
following long-term administration
(https://ntp.niehs.nih.gov/go/1123).
Currently, vincamine appears to be
infrequently marketed in the United
States, while vinpocetine, a semisynthetic derivative of vincamine, is
widely available as a dietary
supplement. In a review of the available
literature, the NTP found that published
data on genotoxicity, carcinogenicity,
and reproductive and developmental
toxicity for vinpocetine are very limited
(https://ntp.niehs.nih.gov/ntp/htdocs/
Chem_Background/ExSumPdf/
Vinpocetine091613_508.pdf). To
address the lack of data and potential
widespread exposure, the NTP is
developing a research program for
toxicological characterization of
vinpocetine.
Request for Information: The NTP
seeks to identify relevant information on
the use, human exposure, and toxicity
of vinpocetine in humans and
experimental animal models. In
particular, information is sought from
unpublished or ongoing research studies
or other sources not readily available.
Any information provided by
respondents will be used to supplement
information the NTP has already
gathered, and will be considered during
the design of one or more types of
experimental toxicology studies of
vinpocetine. Specifically, the NTP
requests the submission of information
regarding:
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00038
Fmt 4703
Sfmt 9990
(1) Exposure, pharmacokinetics,
toxicity, safety, or efficacy of
vinpocetine in humans. (2) Production,
use, and consumption patterns of
vinpocetine in the United States. (3)
Genotoxicity, repeated dose toxicity,
prenatal developmental toxicity,
reproductive toxicity, chronic toxicity,
and carcinogenicity studies of
vinpocetine in experimental animals. (4)
Any other information relative to the
safety or toxicity of vinpocetine not
listed above.
Responses are requested from all
interested parties, such as the research
community, health professionals,
educators, policy makers, industry, and
the public. Responses to this request for
information are voluntary. The NTP
does not intend to publish a summary
of responses received or any other
information provided. Despite this, no
proprietary, classified, confidential, or
sensitive information should be
included in your response. This request
for information is for planning purposes
only and is not a solicitation for
applications or an obligation on the part
of the U.S. Government to provide
support for any ideas identified in
response to it. Please note that the U.S.
Government will not pay for the
preparation of any information
submitted or for its use of that
information. Persons submitting
information should include their name,
affiliation, mailing address, phone, fax,
email address, and sponsoring
organization (if any) with the
submission. The deadline for receipt of
the requested information is November
4, 2013.
Background Information on the NTP:
The NTP is an interagency program
established in 1978 (43 FR 53060) to
strengthen the Department’s activities in
toxicology research and testing, and
develop and validate new and better
testing methods. Other activities of the
program focus on strengthening the
science base in toxicology and
providing information about potentially
toxic chemicals to health regulatory and
research agencies, scientific and
medical communities, and the public.
The NTP is located administratively at
the NIEHS. Information about the NTP
and NIEHS is found at https://
www.niehs.nih.gov and https://
ntp.niehs.nih.gov, respectively.
Dated: September 18, 2013.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2013–23212 Filed 9–23–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 78, Number 185 (Tuesday, September 24, 2013)]
[Notices]
[Pages 58547-58548]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-23082]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neurobiology, genetics, stress and mood/anxiety disorders.
Date: October 10, 2013.
Time: 5:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Washington, DC Convention Center, 900 10th
Street NW., Washington, DC 20001.
Contact Person: Jay Joshi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5196, MSC 7846, Bethesda, MD 20892, (301) 408-
9135, joshij@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Non-HIV Microbial Vaccine Development.
Date: October 18, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Scott Jakes, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301-495-
1506, jakesse@mail.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Biostatistical Methods and Research Design
Study Section.
Date: October 18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Inner Harbor, 301 W. Lombard Street,
Baltimore, MD 21201.
Contact Person: Tomas Drgon, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, 301-435-
1017, tdrgon@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Biomarkers Study Section.
Date: October 18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Houston JW Marriott, 5150 Westheimer Road, Houston, TX
77056.
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-357-9318, ngkl@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Host Interactions with Bacterial Pathogens
Study Section.
Date: October 18, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Fouad A El-Zaatari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD
20892, (301) 435-1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Risk, Prevention and Health Behavior.
Date: October 18, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Claire E Gutkin, Ph.D., MPH, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106, MSC 7808, Bethesda, MD
20892, 301-594-3139, gutkincl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Molecular Neuroscience of Channels and Receptors.
Date: October 18, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
[[Page 58548]]
Contact Person: Carol Hamelink, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD
20892, (301) 213-9887, hamelinc@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 13-213: Outcome Measures for Use in Treatment Trials for
Individuals with Intellectual and Developmental Disabilities (R01).
Date: October 18, 2013.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Jane A Doussard-Roosevelt, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 13-008 Robotic Bioanalytical Shared Instrumentation.
Date: October 18, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181, MSC 7804, Bethesda, MD
20892, belangerm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-23082 Filed 9-23-13; 8:45 am]
BILLING CODE 4140-01-P
